1. ALLA AKTIER
  2. NYHETER
  3. APOTEA

Apotea

Nyheter Apotea Nyheter alla bolag
Slipp dessa annonser och få en massa andra godsaker med vårt premiumabonnemang.

Invitation to Apotea’s presentation of the year-end report 2025

Apotea AB (publ) (”Apotea”) will publish its year-end report Q4 2025 on Wednesday the 4th of February 2026 at 07:30 am CET. Investors, analysts, media and other interested parties are welcome to join a webcast and presentation of the interim report at 09:30 CET the same day.

The results for the period January – December 2025 will be presented by Pär Svärdson, CEO, and Johan Mårild, CFO, via a webcast held 4th of February 2026 at 09:30 am CET.

Link for webcast participation (no advance notification is necessary): https://apotea.events.inderes.com/q4-report-2025

If you wish to participate via teleconference, please register on the link below:
https://events.inderes.com/apotea/q4-report-2025/dial-in

The presentation will be held in English.

Contact
Stefan Eriksson, deputy CEO, press & Investor Relations
E-mail: ir@apotea.se

About Us
Apotea is Sweden’s leading online pharmacy by market share with the goal of becoming the largest
pharmacy in Sweden and hence also in the Nordics. With the widest assortment on the market, low
prices and quick deliveries, Apotea facilitates everyday life for its three million active customers. In
E-barometern’s 2024 customer survey, Apotea was ranked as customers’ favourite e-commerce
store for the seventh consecutive year. Since 2022, the group also operates in Norway through its
Norwegian subsidiary Apotera.

Attachments
Invitation to Apotea’s presentation of the year-end report 2025

Datum 2025-12-18, kl 11:30
Källa MFN
Bifogade filer
Invitation to Apotea’s presentation of the year-end report 2025